SCHEMBL17672886

SCHEMBL17672886

N#Cc1ccc(I)c(-c2ccncc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 3/20 0.48
▸ GCGR P47871 2/20 0.48
▸ PKN1 Q16512 1/20 0.46
▸ PKN2 Q16513 1/20 0.46
▸ CYP11B1 P15538 3/20 0.46
▸ CYP11B2 P19099 3/20 0.46
▸ CYP19A1 P11511 1/20 0.46
▸ PDE3B Q13370 3/20 0.40
▸ PDE3A Q14432 3/20 0.40
▸ FLT3 P36888 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ PDE5A O76074 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ PDE4A P27815 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ PDE4B Q07343 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23627700 0.81 PTGDR2 (0.50) CYP11B2CYP19A1KDM4ETSHR
SCHEMBL17672788 0.80 CYP19A1 (0.43) CYP11B1CYP11B2CYP19A1TSHRCYP2C19
SCHEMBL1424066 0.80 MAOA (0.54) MAPK14GCGRPKN1PKN2CYP11B1
SCHEMBL17672828 0.80 PKN1 (0.45) MAPK14GCGRPKN1PKN2CYP11B1
SCHEMBL17540171 0.80 CYP11B2 (0.55) MAPK14GCGRPKN1PKN2CYP11B1
SCHEMBL17672897 0.80 CYP11B2 (0.60) CYP11B1CYP11B2CYP19A1FLT3KDM4E
SCHEMBL19933113 0.76 GCGR (0.50) MAPK14GCGRPKN1PKN2CYP11B1
SCHEMBL24017211 0.74 KIF11 (0.62) LMNAGSK3B
SCHEMBL24017205 0.74 KDM1A (0.40) CYP11B1CYP11B2LMNA
SCHEMBL31726534 0.74 CA12 (0.47) MAPK14GCGRPKN1PKN2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016055947-A1 ALKYNE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-04-14 — — WO disclosed
Send feedback